Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.542
-0.092 (-13.43%)
Nov 21, 2024, 12:59 PM EST - Market open

Eterna Therapeutics Statistics

Total Valuation

ERNA has a market cap or net worth of $27.85 million. The enterprise value is $65.02 million.

Market Cap 27.85M
Enterprise Value 65.02M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

ERNA has 51.37 million shares outstanding. The number of shares has increased by 11.09% in one year.

Current Share Class 51.37M
Shares Outstanding 51.37M
Shares Change (YoY) +11.09%
Shares Change (QoQ) n/a
Owned by Insiders (%) 48.62%
Owned by Institutions (%) 10.02%
Float 21.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 5.56
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 108.72
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.48

Current Ratio 0.48
Quick Ratio 0.45
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.35

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -42.35%
Return on Capital (ROIC) -71.61%
Revenue Per Employee $74,750
Profits Per Employee -$5.62M
Employee Count 8
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, ERNA has paid $15,000 in taxes.

Income Tax 15,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.60% in the last 52 weeks. The beta is 7.76, so ERNA's price volatility has been higher than the market average.

Beta (5Y) 7.76
52-Week Price Change -45.60%
50-Day Moving Average 1.08
200-Day Moving Average 1.71
Relative Strength Index (RSI) 24.77
Average Volume (20 Days) 130,403

Short Selling Information

The latest short interest is 44,458, so 0.09% of the outstanding shares have been sold short.

Short Interest 44,458
Short Previous Month 61,003
Short % of Shares Out 0.09%
Short % of Float 0.21%
Short Ratio (days to cover) 1.07

Income Statement

In the last 12 months, ERNA had revenue of $598,000 and -$44.95 million in losses. Loss per share was -$8.31.

Revenue 598,000
Gross Profit 436,000
Operating Income -20.32M
Pretax Income -22.90M
Net Income -44.95M
EBITDA -20.18M
EBIT -20.32M
Loss Per Share -$8.31
Full Income Statement

Balance Sheet

The company has $4.26 million in cash and $37.70 million in debt, giving a net cash position of -$33.43 million or -$0.65 per share.

Cash & Cash Equivalents 4.26M
Total Debt 37.70M
Net Cash -33.43M
Net Cash Per Share -$0.65
Equity (Book Value) -45.39M
Book Value Per Share -8.39
Working Capital -5.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.95 million and capital expenditures -$388,000, giving a free cash flow of -$17.34 million.

Operating Cash Flow -16.95M
Capital Expenditures -388,000
Free Cash Flow -17.34M
FCF Per Share -$0.34
Full Cash Flow Statement

Margins

Gross Margin 72.91%
Operating Margin -3,397.66%
Pretax Margin -7,511.37%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -15,845.22%

Dividends & Yields

ERNA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.09%
Shareholder Yield -11.09%
Earnings Yield -142.33%
FCF Yield -54.91%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on October 17, 2022. It was a reverse split with a ratio of 0.05:1.

Last Split Date Oct 17, 2022
Split Type Reverse
Split Ratio 0.05:1

Scores

Altman Z-Score n/a
Piotroski F-Score 3